Who are 18F-PSMA-1007's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Radiopharmaceutical 18F-JK-PSMA-7.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/18f-psma-1007.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

18F-PSMA-1007 — Competitive Intelligence Brief

18F-PSMA-1007 (18F-PSMA-1007) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: PSMA-targeted PET imaging agent. Area: Oncology.

phase 3 PSMA-targeted PET imaging agent PSMA (prostate-specific membrane antigen) Oncology Small molecule Live · refreshed every 30 min

Target snapshot

18F-PSMA-1007 (18F-PSMA-1007) — Affiliated Hospital of Jiangnan University. 18F-PSMA-1007 is a fluorine-18 labeled small molecule that binds to prostate-specific membrane antigen (PSMA) for positron emission tomography (PET) imaging of PSMA-expressing tumors.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
18F-PSMA-1007 TARGET	18F-PSMA-1007	Affiliated Hospital of Jiangnan University	phase 3	PSMA-targeted PET imaging agent	PSMA (prostate-specific membrane antigen)
Radiopharmaceutical 18F-JK-PSMA-7	Radiopharmaceutical 18F-JK-PSMA-7	ITEL Telecomunicazioni Srl	phase 3	PSMA-targeted PET imaging agent	PSMA (prostate-specific membrane antigen)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (PSMA-targeted PET imaging agent class)

Affiliated Hospital of Jiangnan University · 1 drug in this class
ITEL Telecomunicazioni Srl · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). 18F-PSMA-1007 — Competitive Intelligence Brief. https://druglandscape.com/ci/18f-psma-1007. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab